搜索页_+Afatinib

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：85条，耗时：小于0.01 秒

1.An autopsy case of bronchiolitis obliterans as a previously unrecognized adverse event of afatinib treatment

关键词：BO ; bronchiolitis obliterans ; TKI ; tyrosine kinase inhibitor ; EGFR ; epidermal growth factor receptor ; NSCLC ; non-small cell lung cancer ; ILD ; interstitial lung disease ; FEV1 ; forced expiratory volume in 1s

刊名：Respiratory Investigation

出版年：2017

2.Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis

作者：Anna La Salvia¹ ; Antonio Rossi² ; ^{arossi_it@yahoo.it} ; Domenico Galetta³ ; Elisa Gobbini¹ ; Emmanuele De Luca¹ ; Silvia Novello¹ ; Massimo Di Maio¹

关键词：Afatinib ; Erlotinib ; Gefitinib ; Mutation ; NSCLC

刊名：Clinical Lung Cancer

出版年：2017

3.Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer

作者：Christopher D. Jakubowski¹ ; Andrew J. Plodkowski² ; Jason C. Chang³ ; Natasha Rekhtman³ ; Afsheen Iqbal⁴ ; Paul K. Paik¹ ; ⁴ ; Helena A. Yu¹ ; ⁴ ; ^{yuh@mskcc.org}

刊名：Clinical Lung Cancer

出版年：2017

4.Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

作者：Pasqualina Giordano^a ; ^b ; Anna Manzo^a ; Agnese Montanino^a ; Raffaele Costanzo^a ; Claudia Sandomenico^a ; Maria Carmela Piccirillo^b ; Gennaro Daniele^b ; Nicola Normanno^c ; ^d ; Guido Carillio^e ; Gaetano Rocco^f ; Roberto Bianco^g ; Francesco Perrone^b ; Alessandro Morabito^a ; ^{a.morabito@istitutotumori.na.it" class="auth_mail" title="E-mail the corresponding author} ; ^{alessandromorabito1@virgilio.it" class="auth_mail" title="E-mail the corresponding author}

关键词：Afatinib ; NSCLC ; Clinical trials ; EGFR ; Head-neck

刊名：Critical Reviews in Oncology and Hematology

出版年：2016

5.Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer

作者：I. De Pauw^a ; ^{ines.depauw@uantwerpen.be" class="auth_mail" title="E-mail the corresponding author} ; A. Wouters^a ; J. Van den Bossche^a ; M. Peeters^a ; ^b ; P. Pauwels^a ; ^c ; V. Deschoolmeester^a ; ^c ; J.B. Vermorken^a ; ^b ; F. Lardon^a

关键词：Afatinib ; Colorectal cancer ; EGFR ; Combination therapy

刊名：Pharmacology and Therapeutics

出版年：2016

6.Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors

作者：Yuanbiao Tu^a ; ^&dagger ; ; Yiqiang OuYang^a ; ^&dagger ; ; Shan Xu^a ; ^{shanxu9891@126.com" class="auth_mail" title="E-mail the corresponding author} ; Yan Zhu^b ; Gen Li^c ; Chao Sun^a ; Pengwu Zheng^a ; Wufu Zhu^a ; ^{zhuwf@jxstnu.edu.cn" class="auth_mail" title="E-mail the corresponding author} ; ^{zhuwufu-1122@163.com" class="auth_mail" title="E-mail the corresponding author}

关键词：Afatinib ; Cinnamamide ; Synthesis ; Docking ; EGFR inhibitors ; Antitumor activity

刊名：Bioorganic & Medicinal Chemistry

出版年：2016

7.Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

作者：A.J. van der Wekken^a ; ^{a.j.van.der.wekken@umcg.nl" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; A. Saber^bAuthor Vitae ; T.J.N. Hiltermann^aAuthor Vitae ; K. Kok^cAuthor Vitae ; A. van den Berg^bAuthor Vitae ; H.J.M. Groen^aAuthor Vitae

关键词：EGFR ; ALK ; Targeted therapy ; Crizotinib resistance ; Afatinib resistance ; NSCLC

刊名：Critical Reviews in Oncology and Hematology

出版年：2016

8.Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation

作者：Junko Tanizaki^a ; Eri Banno^b ; Yosuke Togashi^b ; ^c ; Hidetoshi Hayashi^a ; ^{hayashi_h@dotd.med.kindai.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Kazuko Sakai^b ; Masayuki Takeda^a ; Hiroyasu Kaneda^a ; ^d ; Kazuto Nishio^b ; Kazuhiko Nakagawa^a

关键词：EGFR mutation ; KRAS mutation ; Afatinib ; Non&ndash ; small cell lung cancer ; Tyrosine kinase inhibitor

刊名：Lung Cancer

出版年：2016

9.Les essais cliniques de phase précoce peuvent-ils prévoir le profil de tolérance des anticancéreux ciblés ?

作者：N. Primas ; J. Abcaya ; C. Mascaux ; F. Barlesi ; ^{fabrice.barlesi@ap-hm.fr}

刊名：Revue des Maladies Respiratoires

出版年：2017

10.Metástasis coroidea como signo de presentación de un adenocarcinoma de pulmón con respuesta a afatinib

作者：M. Contreras-Dí ; az^a ; ^{Mig.contreras@hotmail.com" class="auth_mail" title="E-mail the corresponding author} ; A. Medina-Tapia^a ; G. Martí ; nez-Bernal^b ; T. Rueda-Rueda^a ; F. Ló ; pez-Herrero^a ; F.E. Molina-Socola^a ; J.L. Sá ; nchez-Vicente^a

关键词：Metá ; stasis coroidea ; Adenocarcinoma de pulmón ; Tumores coroideos ; Afatinib ; Mutació ; n EFGR

刊名：Archivos de la Sociedad Española de Oftalmología

出版年：2016

按检索点细分(85)

题名(47)

关键词(31)

文摘(59)

按出版年细分(85)

2027年及以后(14)

2017年(5)

2016年(31)

2015年(13)

2013年(10)

2012年(10)

2011年(2)